Literature DB >> 16863012

Comparison of time to rehospitalization among schizophrenic patients discharged on typical antipsychotics, clozapine or risperidone.

Ching-Hua Lin1, Shih-Chi Lin, Ming-Chao Chen, Shing-Yaw Wang.   

Abstract

BACKGROUND: The purpose of this study was to compare the time to rehospitalization of schizophrenic patients who were discharged from a psychiatric hospital while being treated with typical antipsychotics, clozapine or risperidone. We also assessed other possible predictors of time to rehospitalization.
METHODS: The study monitored the rehospitalization status of all the schizophrenic patients who were discharged from a psychiatric hospital between July 1, 2001 and June 30, 2002 while they were taking typical antipsychotics (n=272), clozapine (n=61) or risperidone (n=49). Rehospitalizations were tracked over a 2-year period using the Kaplan-Meier method. Risk factors associated with rehospitalization were examined by the Cox proportional hazards regression model.
RESULTS: No significant differences in time to rehospitalization were observed among the groups in the first or second year after discharge. Age at onset of schizophrenia was a risk factor for time to rehospitalization over the 1- and 2-year periods.
CONCLUSION: This study demonstrated that atypical antipsychotics did not lengthen the time to rehospitalization. The earlier the age at onset of schizophrenia, the shorter is the time to rehospitalization. Some other factors thought to impact rehospitalization need to be further assayed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16863012     DOI: 10.1016/S1726-4901(09)70254-0

Source DB:  PubMed          Journal:  J Chin Med Assoc        ISSN: 1726-4901            Impact factor:   2.743


  6 in total

1.  Association With Hospitalization and All-Cause Discontinuation Among Patients With Schizophrenia on Clozapine vs Other Oral Second-Generation Antipsychotics: A Systematic Review and Meta-analysis of Cohort Studies.

Authors:  Takahiro Masuda; Fuminari Misawa; Masayuki Takase; John M Kane; Christoph U Correll
Journal:  JAMA Psychiatry       Date:  2019-10-01       Impact factor: 21.596

2.  Claims data-driven modeling of hospital time-to-readmission risk with latent heterogeneity.

Authors:  Suiyao Chen; Nan Kong; Xuxue Sun; Hongdao Meng; Mingyang Li
Journal:  Health Care Manag Sci       Date:  2018-01-25

3.  Two-year rehospitalization rates of patients with newly diagnosed or chronic schizophrenia on atypical or typical antipsychotic drugs: retrospective cohort study.

Authors:  Miroslav Herceg; Vlado Jukić; Domagoj Vidović; Viktorija Erdeljić; Ivan Celić; Oliver Kozumplik; Dario Bagarić; Maja Silobrcić Radić
Journal:  Croat Med J       Date:  2008-04       Impact factor: 1.351

4.  The costs of schizophrenia and predictors of hospitalisation from the statutory health insurance perspective.

Authors:  Jan Zeidler; Lara Slawik; Jochen Fleischmann; Wolfgang Greiner
Journal:  Health Econ Rev       Date:  2012-05-04

5.  Risk of readmission in patients with schizophrenia and schizoaffective disorder newly prescribed clozapine.

Authors:  Jad Kesserwani; Giouliana Kadra; Johnny Downs; Hitesh Shetty; James H MacCabe; David Taylor; Robert Stewart; Chin-Kuo Chang; Richard D Hayes
Journal:  J Psychopharmacol       Date:  2019-01-08       Impact factor: 4.153

6.  Risk factors associated with readmissions of patients with severe mental disorders under treatment with antipsychotics.

Authors:  Ronaldo Portela; Milton Leonard Wainberg; Saulo Castel; Helian Nunes de Oliveira; Cristina Mariano Ruas
Journal:  BMC Psychiatry       Date:  2022-03-17       Impact factor: 3.630

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.